Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE.
Crane (CR) has attracted fresh attention after recent price moves, with the shares last closing at $200.52. Investors are considering its 1 day gain, recent month softness, and stronger performance over the past 3 months.
See our latest analysis for Crane.
Crane’s recent share price gains over the past week sit alongside a softer 30 day share price return of 1.32% and a stronger 90 day share price return of 9.16%. Its 1 year total shareholder return of 17.54% and very large 5 year total shareholder return of around 3x suggest long term momentum has been stronger than the shorter term moves might imply.
If you are reassessing your watchlist after Crane’s recent run, it could be a good moment to broaden your search with our 23 top founder-led companies.
With Crane now at $200.52, trading close to some analysts’ targets but with recent revenue and net income growth, you have to ask yourself: is there still mispricing here, or is the market already baking in future gains?
Crane’s most followed narrative pegs fair value at about $214.22, a bit above the last close of $200.52, which puts its recent rerating into context.
Crane’s recent acquisition of PSI (Druck, Panametrics, Reuter-Stokes) positions the company to capture rising demand for advanced sensing and fluid control in both aerospace and process industries, directly benefiting from infrastructure modernization and growing automation supporting sustained revenue and future margin expansion.
Curious what earnings path and margin profile sit behind that fair value, and what kind of future P/E the narrative assumes? The full story connects revenue growth, margin shifts, and valuation in a way the current share price alone does not spell out.
Result: Fair Value of $214.22 (UNDERVALUED)
Have a read of the narrative in full and understand what’s behind the forecasts.
However, there are still real questions around Europe’s weaker chemical demand and the execution risk of folding PSI into Crane that could challenge this fair value story.
